Cargando…
Whole‐Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta
Mutations in the COL1A1 and COL1A2 genes, which encode type I collagen, are present in around 85%–90% of osteogenesis imperfecta (OI) patients. Because type I collagen is the principal protein composition of bones, any changes in its gene sequences or synthesis can severely affect bone structure. As...
Autores principales: | Omosule, Catherine L., Joseph, Dominique, Weiler, Brooke, Gremminger, Victoria L., Silvey, Spencer, Lafaver, Brittany N., Jeong, Youngjae, Kleiner, Sandra, Phillips, Charlotte L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339096/ https://www.ncbi.nlm.nih.gov/pubmed/37457877 http://dx.doi.org/10.1002/jbm4.10753 |
Ejemplares similares
-
Impact of Intrinsic Muscle Weakness on Muscle–Bone Crosstalk in Osteogenesis Imperfecta
por: Gremminger, Victoria L., et al.
Publicado: (2021) -
Deciphering Myostatin’s Regulatory, Metabolic, and Developmental Influence in Skeletal Diseases
por: Omosule, Catherine L., et al.
Publicado: (2021) -
Osteogenesis imperfecta
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2018) -
Osteogenesis Imperfecta
por: Sam, Justin Easow, et al.
Publicado: (2017) -
Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta
por: DiGirolamo, Douglas J., et al.
Publicado: (2015)